ERAS
ERAS
NASDAQ · Biotechnology

Erasca Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$15.07
-0.01 (-0.07%)
As of Jun 23, 9:57 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 14 82%
Hold 2 12%
Sell 1 6%
Price Target
Analyst Price Target +63.6% upside
Low Target $19.75
Average Target $24.65
High Target $31.92
Current Price $15.07
Current
$15.07
Target
$24.65
$19.75 $24.65 avg $31.92
Scenario Analysis
Bear Case
$19.75
31.1%
Low target
Base Case
$24.65
+63.6%
Avg target
Bull Case
$31.92
+111.8%
High target
Risk/Reward
3.6x
Highly favorable
Price in Context
52-Week High
$24.28
-37.9% from high
52-Week Low
$1.21
+1,145.5% from low
50-Day SMA
$7.48
+101.5% vs SMA
200-Day SMA
$3.25
+363.7% vs SMA
RSI (14)
71.9
Overbought
Target vs 52W High
$24.65
+1.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%